Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Charles Schwab, IBD Stock Of The Day, Eyes Buy Point After Earnings, Upgrade
Charles Schwab, IBD Stock Of The Day, Eyes Buy Point After Earnings, Upgrade · Investor's Business Daily

In This Article:

Charles Schwab stock climbs toward a buy point following an upgrade from Goldman Sachs, Q1 earnings beat. Shares are up 8.5% in 2025.